Actively Recruiting

Age: 18Years +
All Genders
ID03492151

Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions

Led by Ohio State University Comprehensive Cancer Center · Updated on 2025-08-22

500

Participants Needed

10

Research Sites

N/A

Total Duration

On this page

Sponsors

O

Ohio State University Comprehensive Cancer Center

Lead Sponsor

A

American College of Gastroenterology

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying pancreatic cystic lesions (PCL) to improve diagnosis using confocal laser endomicroscopy (nCLE) combined with endoscopic ultrasound (EUS) and cyst fluid analysis. This observational study involves patients referred for EUS evaluation of PCL at academic centers, aiming to assess the accuracy of diagnosing PCL and the risk stratification of intraductal papillary mucinous neoplasms (IPMNs) over 48 months. Participants undergo EUS-guided nCLE imaging followed by EUS-guided fine needle aspiration (FNA) to collect cyst fluid. The fluid is tested for carcinoembryonic antigen (CEA), cytology, and molecular markers as part of standard care. Based on these results and multidisciplinary tumor board recommendations, surgery may be performed, with surgical histopathology serving as the definitive diagnosis. During the study, patients provide consent and receive EUS procedures with imaging and fluid sampling. Researchers measure diagnostic accuracy and imaging quality over 48 months. Most participants are expected to have surgical resection after EUS. The study monitors the accuracy of diagnosis and risk assessment, guiding future care for pancreatic cysts.

CONDITIONS

Brief Title

Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient age 18 years or older
  • Patients referred for EUS-FNA of accessible pancreatic cystic lesions where surgery is considered
  • Pancreatic cyst size of at least 2.0 cm as shown by prior imaging
Not Eligible

You will not qualify if you...

  • Unable to provide informed consent
  • Unable to tolerate the EUS procedure
  • Pregnant women at time of procedure
  • Patient age under 18 years
  • Bleeding disorders
  • Known allergy to fluorescein dye
  • History of pancreatic cancer
  • Previous pancreatic surgery

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Single day

Participants undergo confocal laser endomicroscopy imaging to diagnose pancreatic cystic lesions.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 48 months

Participants are monitored for up to 48 months to assess diagnosis accuracy and imaging quality.

Periodic visits during the monitoring period

Trial Site Locations

Total: 10 locations

1

Mayo Clinic Scottsdale Campus

Scottsdale, Arizona, United States, 85259

Actively Recruiting

2

Stanford Hospital

Stanford, California, United States, 94305

Actively Recruiting

3

Yale School of Medicine

New Haven, Connecticut, United States, 06510

Actively Recruiting

4

Parkview Hospital Randallia

Fort Wayne, Indiana, United States, 46805

Active, Not Recruiting

5

The Johns Hopkins Hospital

Baltimore, Maryland, United States, 21287

Actively Recruiting

6

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02215

Actively Recruiting

7

NYU Langone Health

Garden City, New York, United States, 11530

Actively Recruiting

8

Icahn School of Medicine at Mount Sinai

New York, New York, United States, 10029

Actively Recruiting

9

The Ohio State University Wexner Medical Center

Columbus, Ohio, United States, 43210

Actively Recruiting

10

Baylor College of Medicine

Houston, Texas, United States, 77030

Actively Recruiting

Loading map...

Research Team

M

Megan Fry

D

Diana Burke

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Development of Biomarkers for the Early Detection, Surveilla...

Pancreatic Cancer

Actively Recruiting

13 locations

Artificial Intelligence in Endoscopic Ultrasound to Detect P...

Pancreatic Cancer

Actively Recruiting

1 location

Bio-Repository of High Risk Cohorts for the Early Detection ...

Pancreatic Cyst

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial